Treatment with tacrolimus and an inosine monophosphate dehydrogenase (IMPDH) inhibitor initiated less than or equal to 30 days of transplantation and has remained on both for the 30 days prior to randomization. [clinicaltrials_resource:d78ddf498d1a1a8b63f7a9b1e512f79f]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Treatment with tacrolimus and an inosine monophosphate dehydrogenase (IMPDH) inhibitor initiated less than or equal to 30 days of transplantation and has remained on both for the 30 days prior to randomization. [clinicaltrials_resource:d78ddf498d1a1a8b63f7a9b1e512f79f]
Bio2RDF identifier
d78ddf498d1a1a8b63f7a9b1e512f79f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d78ddf498d1a1a8b63f7a9b1e512f79f
identifier
clinicaltrials_resource:d78ddf498d1a1a8b63f7a9b1e512f79f
title
Treatment with tacrolimus and ...... 0 days prior to randomization.
@en
type
label
Treatment with tacrolimus and ...... ddf498d1a1a8b63f7a9b1e512f79f]
@en